{"entity":{"type":"insider","cik":"0001838283","url":"/insider/0001838283","json_url":"/insider/0001838283.json","name":"Witter Malcolm G","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2020-12-30","last":"2021-09-17","span_basis":"filed_date"},"name_variants":[{"name":"Witter Malcolm G","source":"filing","n_filings":6,"first_seen":"2020-12-30","last_seen":"2021-09-17"}],"transactions":[{"id":4599521,"accession":"0001437749-21-022353","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-022353","line_url":"/filing/0001437749-21-022353#line-1","is_derivative":false,"issuer_cik":"0000810509","issuer_name":"NAVIDEA BIOPHARMACEUTICALS, INC.","issuer_ticker":"NAVB","issuer_name_source":null,"issuer_url":"/issuer/0000810509","owner_cik":"0001838283","owner_name":"Witter Malcolm G","owner_url":"/insider/0001838283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.5976,"price_display":"1.60","price_state":"stated","total_value":31952.0,"total_display":"31,952.00","shares_owned_after":98257.0,"shares_owned_after_display":"98,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-17","scope":"insider"},{"id":4927323,"accession":"0001437749-21-017568","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-017568","line_url":"/filing/0001437749-21-017568#line-1","is_derivative":false,"issuer_cik":"0000810509","issuer_name":"NAVIDEA BIOPHARMACEUTICALS, INC.","issuer_ticker":"NAVB","issuer_name_source":null,"issuer_url":"/issuer/0000810509","owner_cik":"0001838283","owner_name":"Witter Malcolm G","owner_url":"/insider/0001838283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":1.698,"price_display":"1.70","price_state":"stated","total_value":25470.0,"total_display":"25,470.00","shares_owned_after":78257.0,"shares_owned_after_display":"78,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-26","filed_date":"2021-07-26","scope":"insider"},{"id":5069583,"accession":"0001437749-21-009827","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-009827","line_url":"/filing/0001437749-21-009827#line-1","is_derivative":false,"issuer_cik":"0000810509","issuer_name":"NAVIDEA BIOPHARMACEUTICALS, INC.","issuer_ticker":"NAVB","issuer_name_source":null,"issuer_url":"/issuer/0000810509","owner_cik":"0001838283","owner_name":"Witter Malcolm G","owner_url":"/insider/0001838283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.6,"price_display":"1.60","price_state":"stated","total_value":16000.0,"total_display":"16,000.00","shares_owned_after":57000.0,"shares_owned_after_display":"57,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-23","filed_date":"2021-04-26","scope":"insider"},{"id":4095161,"accession":"0001437749-21-007468","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-007468","line_url":"/filing/0001437749-21-007468#line-1","is_derivative":false,"issuer_cik":"0000810509","issuer_name":"NAVIDEA BIOPHARMACEUTICALS, INC.","issuer_ticker":"NAVB","issuer_name_source":null,"issuer_url":"/issuer/0000810509","owner_cik":"0001838283","owner_name":"Witter Malcolm G","owner_url":"/insider/0001838283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21500.0,"shares_display":"21,500","price_per_share":2.07,"price_display":"2.07","price_state":"stated","total_value":44505.0,"total_display":"44,505.00","shares_owned_after":47000.0,"shares_owned_after_display":"47,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-29","filed_date":"2021-03-29","scope":"insider"},{"id":5313986,"accession":"0001437749-21-004857","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-004857","line_url":"/filing/0001437749-21-004857#line-1","is_derivative":false,"issuer_cik":"0000810509","issuer_name":"NAVIDEA BIOPHARMACEUTICALS, INC.","issuer_ticker":"NAVB","issuer_name_source":null,"issuer_url":"/issuer/0000810509","owner_cik":"0001838283","owner_name":"Witter Malcolm G","owner_url":"/insider/0001838283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.31,"price_display":"2.31","price_state":"stated","total_value":34650.0,"total_display":"34,650.00","shares_owned_after":25500.0,"shares_owned_after_display":"25,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-03","scope":"insider"},{"id":3065152,"accession":"0001437749-20-026157","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-026157","line_url":"/filing/0001437749-20-026157#line-1","is_derivative":false,"issuer_cik":"0000810509","issuer_name":"NAVIDEA BIOPHARMACEUTICALS, INC.","issuer_ticker":"NAVB","issuer_name_source":null,"issuer_url":"/issuer/0000810509","owner_cik":"0001838283","owner_name":"Witter Malcolm G","owner_url":"/insider/0001838283","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.07,"price_display":"2.07","price_state":"stated","total_value":10350.0,"total_display":"10,350.00","shares_owned_after":10500.0,"shares_owned_after_display":"10,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-28","filed_date":"2020-12-30","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000810509","name":"NAVIDEA BIOPHARMACEUTICALS, INC.","url":"/issuer/0000810509","role":"Director","n_filings":6,"first_seen":"2020-12-30","last_seen":"2021-09-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001838283","retrieved_at":"2026-08-20T18:16:42+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}